Driehaus Capital Management LLC
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 938206
Chicago, IL
Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$261,189,621
+$57,765,491 QoQ
Shares Held
4,491,653
-1.0% QoQ
Ownership
4.65%
of shares outstanding
% of Portfolio
1.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83.98698652812227.ToString("F0")%
Shared 0.ToString("F0")%
None 16.013013471877724.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Driehaus Capital Management LLC holds $2,981,444,927 across 55 Biotechnology names. XENE ranks #2 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
949,225 | $305,830,802 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
This page
|
4,491,653 | $261,189,621 | |
| 3 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
6,395,922 | $232,299,887 | |
| 4 | APGE |
Apogee Therapeutics, Inc.
|
1,920,800 | $161,673,736 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
4,477,942 | $141,055,173 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
2,790,785 | $140,767,195 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
5,911,889 | $111,734,702 | |
| 8 | SEPN |
Septerna, Inc.
|
4,395,572 | $105,625,595 |
All Filings in XENE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $261,189,621 | 4,491,653 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $201,315,887 | 4,491,653 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $203,424,130 | 4,538,691 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $167,389,927 | 4,169,114 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $135,705,782 | 4,335,648 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $153,822,019 | 4,584,859 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $177,207,324 | 4,520,595 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $180,933,535 | 4,595,721 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $172,315,213 | 4,419,472 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $186,050,907 | 4,321,740 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $200,138,990 | 4,345,180 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $154,164,250 | 4,513,005 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $183,292,840 | 4,760,853 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $166,599,765 | 4,654,925 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $184,603,255 | 4,681,797 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $162,595,122 | 4,504,020 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $133,575,375 | 4,391,038 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $100,894,053 | 3,300,427 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $97,569,673 | 3,123,229 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $23,096,377 | 1,511,543 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $17,598,413 | 945,135 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,808,239 | 771,410 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,850,928 | 445,444 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,995,968 | 451,307 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,821,481 | 464,233 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,242,844 | 462,332 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||